A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01)
- Hye Ryun Kim
- , Joung Soon Jang
- , Jong Mu Sun
- , Myung Ju Ahn
- , Dong Wan Kim
- , Inkyung Jung
- , Ki Hyeong Lee
- , Joo Hang Kim
- , Dae Ho Lee
- , Sang We Kim
- , Byoung Chul Cho
- Yonsei University
- Chung-Ang University
- Sungkyunkwan University
- Seoul National University
- Chungbuk National University
- University of Ulsan
Research output: Contribution to journal › Article › peer-review
13
Link opens in a new tab
Scopus
citations